d-alpha tocopherol has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankwitz, D; Brovko, O; Fiedler, M; Khudyakov, Y; Lange, M; Nassal, M; Osburn, W; Pietschmann, T; Pumpens, P; Roggendorf, M; Timm, J; Viazov, S; Walker, A; Zekri, AR | 1 |
| Ito, T; Kawanaka, M; Mahmood, S; Nakamura, H; Niiyama, G; Okita, M; Sasagawa, T; Sho, M; Togawa, K; Yamada, G; Yodoi, J | 1 |
| Itoshima, T; Kawaguchi, M; Okita, M; Osawa, T; Ota, Y; Sakai, N; Sasagawa, T; Tomioka, K | 1 |
| Kawanaka, M; Nagai, A; Niiyama, G; Okita, M; Ota, Y; Sasagawa, T; Suzuki, K; Tomioka, K; Yamada, G | 1 |
| Nishino, H | 1 |
| Barreto, R; Marotta, F; Naito, Y; Packer, L; Yoshida, C | 1 |
| Khan, DA; Mushtaq, S; Qureshi, AA; Qureshi, N; Silswal, N; Zuvanich, EG | 1 |
| Bransford, P; Dworakowski, W; Kumar, S; Medek, A; Mudunuri, P; Peresypkin, A; Randles, EG; Snyder, PW; Song, B | 1 |
| Chen, W; Duan, L; Hu, Q; Li, P; Liu, J; Wang, B; Yan, Y | 1 |
| Conti, P; De Tullio, D; Falasca, K; Mancino, P; Pizzigallo, E; Ucciferri, C; Vecchiet, J; Vitacolonna, E | 1 |
| Aghdassi, E; Allard, J; Arendt, B; Chow, C; Guindi, M; Lilly, L; Madill, J; Therapondos, G | 1 |
| Afriyie-Gyawu, E; Desmond, RA; Ellis, WO; Jiang, Y; Jolly, PE; Obuseh, FA; Phillips, TD; Piyathilake, CJ; Shuaib, FM; Waterbor, J | 1 |
| Niederau, C; Sies, H; Stahl, W; Strohmeyer, G; von Herbay, A; von Laar, J | 1 |
| Chojkier, M; Houglum, K; Lyche, K; Venkataramani, A | 1 |
| Niederau, C; Sies, H; Stahl, W; von Herbay, A | 1 |
5 trial(s) available for d-alpha tocopherol and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Prevention of hepatocellular carcinoma in chronic viral hepatitis patients with cirrhosis by carotenoid mixture.
Topics: alpha-Tocopherol; Carcinoma, Hepatocellular; Carotenoids; Female; Hepatitis C; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 2007 |
Oxidative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Alanine Transaminase; alpha-Tocopherol; Antioxidants; Carica; Deoxyguanosine; DNA Damage; Female; Fermentation; Fruit; Glutathione; Glutathione Peroxidase; Hepatitis C; Humans; Immunologic Factors; Liver Cirrhosis; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Plant Preparations; Receptors, Tumor Necrosis Factor, Type II; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Diminished plasma levels of vitamin E in patients with severe viral hepatitis.
Topics: Acute Disease; Adult; Aged; Chronic Disease; Female; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Lipids; Male; Middle Aged; Vitamin E | 1996 |
A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.
Topics: Actins; Biopsy; Collagen; Female; Hepatitis C; Humans; In Situ Hybridization; Liver; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myb; Proto-Oncogenes; RNA, Messenger; Trans-Activators; Transcription, Genetic; Vitamin E | 1997 |
Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study.
Topics: Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Double-Blind Method; Female; Hepatitis C; Humans; Male; Middle Aged; Placebos; Vitamin E | 1997 |
10 other study(ies) available for d-alpha tocopherol and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.
Topics: alpha-Tocopherol; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigen Presentation; Antigens, Viral; Capsid Proteins; Cross Protection; Drug Combinations; Escherichia coli; Female; Gene Expression; Hepacivirus; Hepatitis B virus; Hepatitis C; Humans; Immunity, Humoral; Injections, Intramuscular; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Polysorbates; Recombinant Proteins; Squalene; Viral Hepatitis Vaccines; Viral Proteins | 2014 |
Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.
Topics: Aged; Alanine Transaminase; alpha-Tocopherol; Female; Hepatitis C; Humans; Interferons; Male; Middle Aged; Oxidative Stress; Thioredoxins; Time Factors; Vitamin E | 2003 |
Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.
Topics: Aged; alpha-Tocopherol; Arachidonic Acid; Carcinoma, Hepatocellular; Case-Control Studies; Chromatography, Gas; Chromatography, High Pressure Liquid; Disease Progression; Enzyme-Linked Immunosorbent Assay; Fatty Acids; Female; Hepatitis C; Humans; Leukocytes, Mononuclear; Liver Cirrhosis; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Phospholipids; Platelet Count; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2003 |
Vitamin E supplementation increases polyunsaturated fatty acids of RBC membrane in HCV-infected patients.
Topics: Alanine Transaminase; alpha-Tocopherol; Arachidonic Acid; Dietary Supplements; Docosahexaenoic Acids; Erythrocyte Membrane; Fatty Acids, Unsaturated; Female; Hepatitis C; Humans; Male; Middle Aged; Phospholipids | 2004 |
Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs.
Topics: 2-Methoxyestradiol; Apoptosis; Cell Line, Tumor; Cell Survival; Cells, Cultured; Estradiol; Hepatitis C; Humans; NF-kappa B; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Quercetin; Signal Transduction; Tocotrienols; Vitamin E | 2018 |
Overcoming the Bile Salt-Mediated Formation of Nanocolloids That Inhibit Oral Absorption of VX-985.
Topics: Administration, Oral; Animals; Antiviral Agents; Biological Availability; Colloids; Drug Carriers; Hepacivirus; Hepatitis C; Humans; Intestinal Absorption; Protease Inhibitors; Rats; Solubility; Spiro Compounds; Taurocholic Acid; Vitamin E | 2019 |
Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.
Topics: Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Carriers; Hepatitis C; Hepatocytes; Humans; Liposomes; Mice, Inbred BALB C; Nanoparticles; RNA, Small Interfering; Vitamin E | 2016 |
Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection.
Topics: Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cytokines; Female; Hepatitis C; Humans; Liver Function Tests; Male; Middle Aged; Silybin; Silymarin; Treatment Outcome; Viral Load; Vitamin E | 2008 |
Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients.
Topics: Antioxidants; Ascorbic Acid; Body Height; Body Mass Index; Body Weight; Diabetes Complications; Diabetes Mellitus; Female; Hepatitis C; Humans; Lipid Peroxides; Liver Transplantation; Male; Middle Aged; Oxidative Stress; Recurrence; Vitamin A; Vitamin E; Waist-Hip Ratio | 2010 |
Aflatoxin B1 albumin adducts in plasma and aflatoxin M1 in urine are associated with plasma concentrations of vitamins A and E.
Topics: Adult; Aflatoxin B1; Aflatoxin M1; Aflatoxins; Albumins; Antibodies, Viral; Cross-Sectional Studies; Female; Ghana; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis C; Humans; Liver Function Tests; Male; Multivariate Analysis; Regression Analysis; Socioeconomic Factors; Vitamin A; Vitamin E; Young Adult | 2010 |